Navigation Links
New Oral-B(R) Triumph(TM) With SmartGuide(TM) is the First Power Toothbrush With a Wireless Display
Date:9/28/2007

New Product Clinically Proven to Improve Brushing Habits

SAN FRANCISCO, Sept. 28 /PRNewswire-FirstCall/ -- Oral-B(R), the world's leading toothbrush brand, today announced the launch of Oral-B(R) Triumph(TM) with SmartGuide(TM) at this year's American Dental Association (ADA) Annual Session. Triumph is Oral-B's smartest toothbrush that now comes with a wireless display that visually helps consumers improve their brushing habits to promote cleaner teeth and healthier gums.

The average person spends about 47 seconds brushing his or her teeth, less than half the 2 minutes dentists recommend.(3) Many people brush too hard, which can contribute to early gum recession. The experts at Oral-B wanted to help consumers brush the way dentists recommend, thoroughly and gently. Their team of scientists and engineers created the Triumph with SmartGuide combining wireless technology with the most common learning style - visual stimulation - to improve consumers' brushing habits.

This latest toothbrush from Oral-B features Smart Technology, in which the brushhead, handle and now visual display work together so users can receive visual cues that help them brush better. The unique FlossAction brushhead and handle are embedded with microchips. The handle communicates with the wireless display to signal when you are brushing too hard, when to move to the next quadrant of the mouth, when you have brushed for two minutes, and when it is time to replace the brushhead.

"We wanted to take our best technology to the next level," said Dr. Paul Warren, dentist and vice president, Global Professional and Scientific Relations, P&G Oral Care. "The Oral-B Triumph has been clinically proven to prevent and reverse gingivitis and to provide outstanding plaque removal. Now, we've created the only power toothbrush that addresses one of the most common problems seen by dentists and hygienists - improper brushing habits."

Those who use the Triumph with SmartGui
'/>"/>

SOURCE Oral-B
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Infant receives first bloodless liver transplant
3. Oracle Corp. to help build worlds first "Digital Hospital"
4. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
5. First human clone is near
6. First Artificial Heart patient has Major setback
7. FDA approves first pocket-sized EKG machine
8. First head-to-head trials of once weekly Fosamax and Actonel therapies
9. WHO Declares Vietnam First Country to Control SARS
10. Russia Reports First SARS Case
11. Hope for First New Melanoma Treatment in Decades
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...rter financial results -, LAVAL, QC, July 25 /PRN...DAQ: DDSS) today announced that it will host a con... to discuss its second quarter 2008,financial resu... financial,results via news release at approximate...nce call by telephone, dial 416-646-3095 or,1-800-...
(Date:7/25/2008)...erweight or obese is not only a personal issue tha... issue that impacts other people in society. A new...eveals that the extra Medicare cost associated wit...ant financial burden on tax payers, costing up to ...current Medicare population. , The article,s fi...
(Date:7/25/2008)...Fourth Annual Physician On-Call Pay ...swire/ -- Sullivan, Cotter and Associates, Inc.,ha...on-call pay rates and,practices, the 2008 Physicia...th data from 132 healthcare organizations nationwi...ates paid for 33 physician specialty areas along,w...
(Date:7/25/2008)...ire/ -- Sagent Pharmaceuticals, Inc.,a privately-...nced that it,has launched amiodarone HCl injection...e treatment and prophylaxis of frequently recurrin...table ventricular,tachycardia -- a potentially lif...arone HCl injection will be available immediately ...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3
... U.S. is getting metamorphosed into luxurious buil...ipments which may offer good patient hospitality b...g to non-accessible of poor patients to these luxu...s changing from a semi-private health system to co...
...licy to Briton citizen could increase advertising ...y is aimed at // reducing the waiting time of th...eople can make their own choice of treatment at an... their comfortable location and choice. Health Sec...
...hat is mainly present in pain relievers. Recently ...ing the // clinicians complaining about over dosa...re of the liver but about 50% of these cases are u...yl, Contac, Excedrin, Robitussin, Nyquil and Sinut...
...ty of California have now established a very stron...ure, or end-stage renal disease. So if you are thi...away, as there is no time to lose. // "There are...ure, but it hasn't been appreciated much that kidn...
Other Medicine News:Health News:Painkillers Lead To Liver Failure 2
(Date:7/24/2008)... New JIT Enrollment Program Speeds Oncology... Pharmatech, Inc., a Research Management,Organizat...ceutical,companies to provide research and site ma...the Just-in-Time (JIT) enrollment strategy. The ne...: follicular Non-Hodgkin,s,Lymphoma, Metastatic Br...
(Date:7/24/2008)... NEW YORK, July 24 /- Mac...y announced results of a Phase 2 clinical trial,in...multi-center,open-label efficacy and safety study...treatment of onychomycosis (nail fungus). The comp...complete cure" defined as,negative mycology (negat...
(Date:7/23/2008)... - Nexavar is First Approved Systemic Therapy to... Calif., July 23 /-,Bayer H..., Inc. (Nasdaq:,ONXX) today announced that The New...a Phase 3 trial demonstrating that Nexavar(R) (sor...th by 31 percent in patients with,unresectable hep...
(Date:7/23/2008)... SEATTLE, July 23 /- Sound Pharmace...g Application with the FDA for the clinical,testin...prevention of,chemotherapy induced hearing loss or... SPI-3005, will be tested in advanced stage lung c...platinum based chemotherapy.,This marks the second...
Breaking Medicine Technology:Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Rocky water source 3607 1Rocky water source 3607 2Sex offenders register provides limited protection for children 21576 1Sex offenders register provides limited protection for children 21576 2Raloxifene Cuts Risk of Certain Type of Breast Cancer 21573 1Raloxifene Cuts Risk of Certain Type of Breast Cancer 21573 2Harris Corporations Jim Traficant Addresses Florida Agency for Health Care Administration 21570 1Harris Corporations Jim Traficant Addresses Florida Agency for Health Care Administration 21570 2
LigaSure system generator, bipolar only. Designed to permanently seal vessels and tissue bundles.
Sabre 180 is a powerful niche generator.
Sabre 180 is a powerful niche generator.
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator.
Medicine Products: